ici 89406 has been researched along with 3-hydroxybenzylhydrazine in 1 studies
| Studies (ici 89406) | Trials (ici 89406) | Recent Studies (post-2010) (ici 89406) | Studies (3-hydroxybenzylhydrazine) | Trials (3-hydroxybenzylhydrazine) | Recent Studies (post-2010) (3-hydroxybenzylhydrazine) |
|---|---|---|---|---|---|
| 45 | 1 | 2 | 273 | 0 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goshima, Y; Misu, Y; Nakamura, S | 1 |
1 other study(ies) available for ici 89406 and 3-hydroxybenzylhydrazine
| Article | Year |
|---|---|
L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic beta-Antagonists; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Dopamine; Electric Stimulation; Hydrazines; Hypothalamus; In Vitro Techniques; Kinetics; Levodopa; Male; Norepinephrine; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1990 |